Summary of Key Points Core Viewpoint - The Hong Kong biotechnology sector experienced a significant decline, with most stocks falling sharply, indicating a bearish trend in the market [1]. Company Performance - Gilead Sciences (歌礼制药-B): Decreased by 15.06%, latest price at 15.510, market cap at 14.946 billion [2]. - Yunkang Group (云康集团): Fell by 14.18%, latest price at 2.300, market cap at 1.429 billion [2]. - PAG Pharmaceuticals (派格生物医药-B): Dropped by 9.15%, latest price at 31.760, market cap at 12.258 billion [2]. - Tengsheng Boao (腾盛博药-B): Declined by 8.30%, latest price at 2.210, market cap at 1.590 billion [2]. - China Antibody (中国抗体-B): Decreased by 7.49%, latest price at 3.210, market cap at 4.371 billion [2]. - Jiahua Biotech (嘉和生物-B): Fell by 7.08%, latest price at 4.460, market cap at 2.347 billion [2]. - Sillod Pharmaceuticals (思路迪医药股份): Dropped by 6.06%, latest price at 7.910, market cap at 2.042 billion [2]. - Tiger Med (泰格医药): Decreased by 5.73%, latest price at 54.250, market cap at 46.711 billion [2]. - Kangji Medical (加科思-B): Fell by 5.69%, latest price at 8.120, market cap at 6.404 billion [2]. - WuXi AppTec (药明巨诺-B): Dropped by 5.14%, latest price at 5.720, market cap at 2.382 billion [2]. - Three Leaf Clover Biotech (三叶草生物-B): Decreased by 5.13%, latest price at 0.740, market cap at 0.960 billion [2]. - Yiming Oncology (宜明昂科-B): Fell by 4.76%, latest price at 12.810, market cap at 5.218 billion [2]. - Junshi Biosciences (君实生物): Decreased by 4.69%, latest price at 34.540, market cap at 35.462 billion [2]. - Zhonghui Biotech (中慧生物-B): Fell by 4.39%, latest price at 51.150, market cap at 20.125 billion [2]. - Zhaoyan New Drug (昭衍新药): Decreased by 4.38%, latest price at 23.140, market cap at 17.343 billion [2].
港股生物科技股多数下跌，云康集团跌超14%，腾盛博药跌超8%